We design, develop and manufacture solutions to analyse human respiration using exhaled biomarkers. Our first solution, evernoa, measures the fraction of exhaled nitric oxide (FeNO) to provide relevant information on airway inflammation in a minimally invasive, fast and simple way, useful in the diagnosis and monitoring of respiratory diseases.